250 related articles for article (PubMed ID: 22275124)
1. Tumor suppressor function of RUNX3 in breast cancer.
Chen LF
J Cell Biochem; 2012 May; 113(5):1470-7. PubMed ID: 22275124
[TBL] [Abstract][Full Text] [Related]
2. RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α.
Huang B; Qu Z; Ong CW; Tsang YH; Xiao G; Shapiro D; Salto-Tellez M; Ito K; Ito Y; Chen LF
Oncogene; 2012 Jan; 31(4):527-34. PubMed ID: 21706051
[TBL] [Abstract][Full Text] [Related]
3. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.
Lau QC; Raja E; Salto-Tellez M; Liu Q; Ito K; Inoue M; Putti TC; Loh M; Ko TK; Huang C; Bhalla KN; Zhu T; Ito Y; Sukumar S
Cancer Res; 2006 Jul; 66(13):6512-20. PubMed ID: 16818622
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the RUNX3 gene by promoter hypermethylation and hemizygous deletion in breast cancer.
Hwang KT; Han W; Bae JY; Hwang SE; Shin HJ; Lee JE; Kim SW; Min HJ; Noh DY
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S24-31. PubMed ID: 17923751
[TBL] [Abstract][Full Text] [Related]
5. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.
Subramaniam MM; Chan JY; Soong R; Ito K; Ito Y; Yeoh KG; Salto-Tellez M; Putti TC
Breast Cancer Res Treat; 2009 Jan; 113(1):113-21. PubMed ID: 18256927
[TBL] [Abstract][Full Text] [Related]
6. RUNX3 Epigenetic Inactivation Is Associated With Estrogen Receptor Positive Breast Cancer.
Liu H; Yan Z; Yin Q; Cao K; Wei Y; Rodriguez-Canales J; Ma D; Wu Y
J Histochem Cytochem; 2018 Oct; 66(10):709-721. PubMed ID: 30133331
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between the methylation status of Runx3 gene and positive expression of estrogen receptor in breast cancer].
Yan Z; Gao S; Wu X; Liu H
Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):240-4. PubMed ID: 25975905
[TBL] [Abstract][Full Text] [Related]
8. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of the RUNX3 gene in lung cancer.
Sato K; Tomizawa Y; Iijima H; Saito R; Ishizuka T; Nakajima T; Mori M
Oncol Rep; 2006 Jan; 15(1):129-35. PubMed ID: 16328045
[TBL] [Abstract][Full Text] [Related]
10. Cancer research. Dispute over tumor suppressor gene Runx3 boils over.
Normile D
Science; 2011 Oct; 334(6055):442-3. PubMed ID: 22034407
[No Abstract] [Full Text] [Related]
11. Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer.
Nicole Tsang YH; Wu XW; Lim JS; Wee Ong C; Salto-Tellez M; Ito K; Ito Y; Chen LF
Oncogene; 2013 Mar; 32(12):1488-96. PubMed ID: 22580604
[TBL] [Abstract][Full Text] [Related]
12. RUNX3 is multifunctional in carcinogenesis of multiple solid tumors.
Chuang LS; Ito Y
Oncogene; 2010 May; 29(18):2605-15. PubMed ID: 20348954
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of determining the hypermethylation of the RUNX3 gene promoter and its cohypermethylation with the BRCA1 gene for patients with breast cancer.
Rossokha Z; Fishchuk L; Lobanova O; Vershyhora V; Medvedieva N; Cheshuk V; Vereshchako R; Podolska S; Gorovenko N
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11919-11927. PubMed ID: 37420018
[TBL] [Abstract][Full Text] [Related]
14. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3.
Tan SH; Ida H; Lau QC; Goh BC; Chieng WS; Loh M; Ito Y
Oncol Rep; 2007 Nov; 18(5):1225-30. PubMed ID: 17914577
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance and potential drug target of RUNX3 in breast cancer.
Yu YY; Chen C; Kong FF; Zhang W
Drug Des Devel Ther; 2014; 8():2423-30. PubMed ID: 25525332
[TBL] [Abstract][Full Text] [Related]
17. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.
Han YX; Liang DY
Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of RUNX3 in cancer metastasis (Review).
Chen F; Liu X; Bai J; Pei D; Zheng J
Oncol Rep; 2016 Mar; 35(3):1227-36. PubMed ID: 26708741
[TBL] [Abstract][Full Text] [Related]
19. The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer.
Kodach LL; Jacobs RJ; Heijmans J; van Noesel CJ; Langers AM; Verspaget HW; Hommes DW; Offerhaus GJ; van den Brink GR; Hardwick JC
Carcinogenesis; 2010 Sep; 31(9):1567-75. PubMed ID: 20631058
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3.
Kang KA; Zhang R; Kim GY; Bae SC; Hyun JW
Tumour Biol; 2012 Apr; 33(2):403-12. PubMed ID: 22274925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
